Wikisage, the free encyclopedia of the second generation, is digital heritage
Jump to navigation Jump to search
- Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?
- Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
- T-Cell Replete Haploidentical Bone Marrow Transplantation And Post-Transplant Cyclophosphamide For Patients With Inborn Errors
- Haploidentical Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Aggressive Lymphomas: How Far Have We Come and Where Are We Going?